Evolent Health, Inc. (EVH)

USD 10.71

(-1.47%)

Total Debt Summary of Evolent Health, Inc.

Evolent Health, Inc.'s latest annual total debt in 2023 was 644.79 Million USD , up 35.43% from previous year.
Evolent Health, Inc.'s latest quarterly total debt in 2024 Q2 was 819.91 Million USD , down -0.54% from previous quarter.
Evolent Health, Inc. reported annual total debt of 476.11 Million USD in 2022, up 69.76% from previous year.
Evolent Health, Inc. reported annual total debt of 280.46 Million USD in 2021, down -22.05% from previous year.
Evolent Health, Inc. reported quarterly total debt of 819.91 Million USD for 2024 Q2, down -0.54% from previous quarter.
Evolent Health, Inc. reported quarterly total debt of 644.79 Million USD for 2023 Q4, down -1.34% from previous quarter.

Annual Total Debt Chart of Evolent Health, Inc. (2023 - 2012)

Historical Annual Total Debt of Evolent Health, Inc. (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	644.79 Million USD	35.43%
2022	476.11 Million USD	69.76%
2021	280.46 Million USD	-22.05%
2020	359.78 Million USD	-2.44%
2019	368.79 Million USD	66.84%
2018	221.04 Million USD	82.09%
2017	121.39 Million USD	0.92%
2016	120.28 Million USD	0.0%
2015	- USD	0.0%
2014	- USD	0.0%
2013	- USD	0.0%
2012	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	824.36 Million USD	27.85%
2024 Q2	819.91 Million USD	-0.54%
2023 Q4	644.79 Million USD	-1.34%
2023 FY	644.79 Million USD	35.43%
2023 Q2	695.8 Million USD	10.05%
2023 Q3	653.55 Million USD	-6.07%
2023 Q1	632.27 Million USD	32.8%
2022 Q4	476.11 Million USD	-0.26%
2022 FY	476.11 Million USD	69.76%
2022 Q3	477.33 Million USD	37.12%
2022 Q2	348.1 Million USD	0.78%
2022 Q1	345.39 Million USD	23.15%
2021 Q3	301.78 Million USD	0.9%
2021 Q1	296.56 Million USD	-17.57%
2021 Q2	299.08 Million USD	0.85%
2021 FY	280.46 Million USD	-22.05%
2021 Q4	280.46 Million USD	-7.06%
2020 Q1	363.42 Million USD	-1.46%
2020 Q3	357.38 Million USD	19.23%
2020 Q4	359.78 Million USD	0.67%
2020 FY	359.78 Million USD	-2.44%
2020 Q2	299.74 Million USD	-17.52%
2019 Q4	368.79 Million USD	21.34%
2019 FY	368.79 Million USD	66.84%
2019 Q1	223.32 Million USD	1.03%
2019 Q3	303.94 Million USD	0.95%
2019 Q2	301.08 Million USD	34.82%
2018 FY	221.04 Million USD	82.09%
2018 Q4	221.04 Million USD	81.06%
2018 Q3	122.08 Million USD	0.19%
2018 Q2	121.85 Million USD	0.19%
2018 Q1	121.62 Million USD	0.19%
2017 Q2	120.93 Million USD	0.19%
2017 Q3	121.16 Million USD	0.19%
2017 FY	121.39 Million USD	0.92%
2017 Q1	120.7 Million USD	0.35%
2017 Q4	121.39 Million USD	0.19%
2016 FY	120.28 Million USD	0.0%
2016 Q1	- USD	0.0%
2016 Q2	- USD	0.0%
2016 Q4	120.28 Million USD	0.0%
2016 Q3	- USD	0.0%
2015 Q1	- USD	0.0%
2015 Q2	- USD	0.0%
2015 Q4	- USD	0.0%
2015 Q3	- USD	0.0%
2015 FY	- USD	0.0%
2014 FY	- USD	0.0%
2014 Q1	- USD	0.0%
2014 Q4	- USD	0.0%
2014 Q3	- USD	0.0%
2013 FY	- USD	0.0%
2013 Q4	- USD	0.0%
2012 FY	- USD	0.0%

Peer Total Debt Comparison of Evolent Health, Inc.

Name	Total Debt	Total Debt Difference
American Well Corporation	11.78 Million USD	-5370.864%
Doximity, Inc.	14.54 Million USD	-4332.806%
MultiPlan Corporation	4.56 Billion USD	85.884%
Phreesia, Inc.	11.98 Million USD	-5280.923%
Teladoc Health, Inc.	1.59 Billion USD	59.505%
Veeva Systems Inc.	55.77 Million USD	-1056.066%